Larvol Delta - Tregulaire-Effects-of-Tregalizumab-on-Allergeninduced-Airway-Responses-and-Airway-Inflammation-in-Asthmatic-Patients

tregalizumab (BT-061) - ADMA Biologics, T-Balance Therapeutics

http://clinicaltrials.gov/ct2/show/NCT04673591

Feb 8, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next